Advertisement
In a series of 101 newborns of mothers with perinatal severe acute respiratory syndrome coronavirus 2

No Evidence Found of Vertical Transmission of SARS-CoV-2

0
Newborns of mothers with severe/critical COVID-19 born early, at risk for needing phototherapy
Black and Hispanic patients with cancer used telehealth less often than White patients during the COVID-19 pandemic in New York City

Telehealth Disparity Seen in Cancer Care

0
Black, Hispanic patients with cancer significantly less likely to use video telehealth versus White patients
A study to assess whether certain approved or experimental drugs are effective against COVID-19 and warrant testing in large clinical trials has been launched by the U.S. National Institutes of Health (NIH).

NIH Launches Trial of Antibody Drugs Against COVID-19

0
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
By treating or preventing infection

Glecaprevir and Pibrentasvir Aid HCV D&#43/R− Kidney Transplants

0
Two studies demonstrate safe transplant of kidneys from deceased donors with HCV infection
Sitagliptin treatment added to standard care is associated with reduced mortality and improved clinical outcomes for patients with type 2 diabetes hospitalized with COVID-19

Sitagliptin May Cut Mortality in T2DM Patients With COVID-19

0
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Lack of knowledge is one of the barriers to use of prone positioning for acute respiratory distress syndrome

Lack of Knowledge Barrier to Prone Positioning Use in ARDS

0
Implementation strategies developed included educational outreach, learning collaborative
Black and Mixed/Other ethnicity are independently associated with greater hospital admission risk due to COVID-19 but are not associated with in-hospital mortality risk

Black Race Tied to COVID-19 Admissions, but Not Deaths

0
In-hospital mortality higher for Asian patients, despite lower risk for hospital admission
Enrollment in a study testing an experimental antibody therapy against COVID-19 has been paused by independent monitors.

COVID-19 Antibody Treatment Study Paused

0
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
Protective antibodies persist for months in patients who survive serious COVID-19 infections

Immune Responses Long-Lasting After Serious COVID-19

0
IgG levels remain elevated for four months in patients with symptoms lasting for 14 days
Individuals with blood group O may have a reduced risk for severe acute respiratory syndrome coronavirus 2 infection

Individuals With Blood Group O Have Lower Risk for COVID-19

0
And more COVID-19 patients with blood group A or AB require mechanical ventilation, CRRT